CompletedPhase 2NCT00349726

Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: NICHD Neonatal Research Network
Principal Investigator: Abbot R. Laptook, MD
Brown University, Women & Infants Hospital of Rhode Island
Intervention: Inositol lower volume(drug)
Enrollment: 74 enrolled
Eligibility: All sexes
Timeline: 2006 – 2007

Study locations (11)

Yale University, New Haven, Connecticut, United States
Indiana University, Indianapolis, Indiana, United States
Wayne State University, Detroit, Michigan, United States
University of New Mexico, Albuquerque, New Mexico, United States
University of Rochester, Rochester, New York, United States
RTI International, Durham, North Carolina, United States
Duke University, Durham, North Carolina, United States
Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
University of Utah, Salt Lake City, Utah, United States

Collaborators

National Eye Institute (NEI) · National Center for Research Resources (NCRR) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00349726 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia →

← Back to all trials